Skip to main content
Premium Trial:

Request an Annual Quote

Labsco to Distribute Cepheid GeneXpert Products to Small US Hospitals


Cepheid said this week that it has named Labsco as a US distribution partner for its GeneXpert Systems and tests.

Under the agreement, Labsco has exclusive US distribution rights to sell Cepheid's products to acute care hospitals with fewer than 150 beds. Cepheid said that the agreement does not include its higher-throughput GeneXpert Infinity System.

Labsco, based in Louisville, Ky., has also received non-exclusive rights to the non-acute care, non-hospital market, which includes surgical centers affiliated with hospitals, independent surgical centers, physicians' offices labs, group practices, and nursing homes.

"There are more than 3,900 US hospitals with less than 150 beds which have not been a primary focus of Cepheid to date," Nico Arnold, executive vice president of worldwide operations for Cepheid, said in a statement. "The decision to engage on a nationwide basis with Labsco is in line with one of our strategic growth objectives directed at expanding our reach within the US market."

Cepheid said that it will continue to focus its direct sales efforts on the approximately 2,100 hospitals that have 150 or more beds.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.